Biomarker: K076-IgE Isocyanate MDI

Overview

K076-IgE Isocyanate MDI measures serum immunoglobulin E (IgE) antibodies that recognize methylene diphenyl diisocyanate (MDI), an industrial isocyanate. Detectable MDI-specific IgE indicates immunologic sensitization and may support evaluation of MDI-related occupational asthma. A positive result is strongly suggestive in an appropriately exposed person, but a negative result does not exclude disease because specific IgE is absent in many affected workers. The test is therefore used as an adjunct to occupational history, respiratory testing, and, when appropriate, specialized inhalation or bronchial challenge assessment.

Clinical Use Cases

Support evaluation of suspected MDI-induced occupational asthma.
Identify MDI as a possible occupational respiratory sensitizer in an exposed worker.
Help distinguish MDI sensitization from exposure to other isocyanates when the clinical history is compatible.
Provide immunologic evidence that may complement spirometry, serial peak-flow measurements, bronchial responsiveness testing, and occupational exposure assessment.
Support occupational-health investigations of workplace respiratory symptoms.

Specimen Types

Serum, typically collected from venous blood.

Measurement Methods

Fluorescence enzyme immunoassay using MDI-protein conjugates, commonly an ImmunoCAP-based assay.
Enzyme-linked immunosorbent assay using MDI conjugated to human serum albumin or another carrier protein.
Historically, radioallergosorbent testing has been used for MDI-specific IgE.
Results may be reported quantitatively in kilo units per liter (kU/L) and may also be assigned an assay-specific class or interpretation.

Test Preparation and Influencing Factors

Fasting is generally not required for serum-specific IgE measurement.
Recent or ongoing MDI exposure may affect the likelihood of detecting specific IgE, but the relationship between exposure timing and results is not fully standardized.
IgE has a short serum half-life, and levels may decline after time away from the workplace.
Antihistamines generally do not alter serum-specific IgE concentrations, although they may affect skin-prick testing performed as part of the broader evaluation.
Results can be influenced by the specific MDI-protein conjugate, assay platform, and laboratory cutoff.
MDI-specific IgE is not sufficiently sensitive to serve as a stand-alone screening test for MDI-induced occupational asthma.
A positive result demonstrates sensitization, not necessarily clinical asthma or proof that workplace exposure caused symptoms.
Interpretation should consider exposure history, symptom timing, pulmonary-function findings, and other causes of asthma or respiratory irritation.
Cross-reactivity among different isocyanates may be incomplete and variable, so a negative result for MDI does not assess sensitization to other isocyanates.